Intervention Improves Cognitive Symptoms in Cancer Survivors

Share this content:
Intervention Improves Cognitive Symptoms in Cancer Survivors
Intervention Improves Cognitive Symptoms in Cancer Survivors

TUESDAY, Nov. 1, 2016 (HealthDay News) -- A web-based cognitive rehabilitation program can improve cognitive symptoms in cancer survivors, according to a study published online Oct. 28 in the Journal of Clinical Oncology.

Victoria J. Bray, from Liverpool Hospital in Sydney, and colleagues recruited 242 adult cancer survivors with a primary malignancy who had completed three or more cycles of adjuvant chemotherapy in the previous six to 60 months and reported persistent cognitive symptoms. Participants received a 30-minute telephone consultation and were then randomized to either a 15-week, home-based intervention or to standard care.

The researchers found that the primary outcome of difference in self-reported cognitive function (Functional Assessment of Cancer Therapy Cognitive Function [FACT-COG]) perceived cognitive impairment [PCI] subscale) was significant, with less PCI in the intervention group after the intervention (P < 0.001); this difference persisted six months later (P < 0.001). There was a significant difference in all FACT-COG subscales after the intervention, favoring the intervention. There were no significant differences between the groups in neuropsychological results. After the intervention there were significantly lower levels of anxiety/depression and fatigue noted in the intervention group.

"The intervention, Insight, led to improvements in cognitive symptoms compared with standard care," the authors write. "To our knowledge, this is the first large randomized controlled trial showing an improvement in self-reported cognitive function in cancer survivors, indicating that this intervention is a feasible treatment."

Several authors disclosed financial ties to the pharmaceutical industry.

Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Gene Tx Approved for Certain Types of B-Cell Lymphoma

Gene Tx Approved for Certain Types of B-Cell ...

First such treatment for certain types of non-Hodgkin lymphoma

Uninsurance Down by One-Third for Cancer Diagnoses in 2014

Uninsurance Down by One-Third for Cancer Diagnoses in ...

Significant decreases in uninsurance seen across all stages and sites assessed in first year of ACA

Diabetes Ups Risk of MACE in Acute Coronary Syndromes

Diabetes Ups Risk of MACE in Acute Coronary ...

Diabetes, but not pre-diabetes, tied to increased risk of major adverse cardiac events in adjusted model

is free, fast, and customized just for you!

Already a member?

Sign In Now »